Diagnostic Test
Leukocyte Adherence Inhibition Test
Diagnostics
Overview
Test for cell-mediated antitumor immunity and related serum blocking factors based on the finding that leukocytes from cancer patients, but not from controls, when mixed in vitro with antigenic extracts of tumors of the same histological type, undergo a diminution in their normal adherence to glass surfaces. Sera from tumor-bearing patients block the LAI reaction of their own leukocytes or those of other patients with the same type of tumor.
This information is general and should not be treated as medical advice. Always speak directly with a qualified healthcare professional before making decisions about treatment, diagnosis, procedures, medicines or care.
Quick facts about Leukocyte Adherence Inhibition Test
- Topic type
- Diagnostic Test
- Category
- Diagnostics
- MeSH classification
- E01.370.225.812.460|E05.200.812.460|E05.478.594.500
Questions to discuss about Leukocyte Adherence Inhibition Test
- What does this topic mean in my situation?
- Which type of healthcare professional should I speak with?
- Are tests, assessments or follow-up appointments needed?
- What treatment options or next steps may be relevant?
- Where can I find reliable information before making decisions?
Finding care related to Leukocyte Adherence Inhibition Test
EuroCareFinder helps patients explore clinics and healthcare providers across Europe. Some topics link directly to services offered by clinics, while others may be connected through related specialties, treatments or procedures.
Explore clinics across Europe
Browse the wider EuroCareFinder healthcare network using the interactive map.
Clinics related to Leukocyte Adherence Inhibition Test
No clinics are currently linked directly to Leukocyte Adherence Inhibition Test on EuroCareFinder.
As more clinics add detailed services, related providers may appear here.
Related topics
Explore healthcare providers
Use EuroCareFinder to browse clinics by country, specialty and available services.
Source: Medical Subject Headings (MeSH), produced by the U.S. National Library of Medicine. EuroCareFinder is not endorsed by the National Library of Medicine. MeSH version: 2026.